FDA authorises marketing of first device that uses artificial intelligence to help detect potential signs of colon cancer

9 April 2021 - Medical device aids clinicians in detecting potential irregularities during colon cancer screening and surveillance. ...

Read more →

Optellum receives FDA clearance for the world’s first AI-powered clinical decision support software for early lung cancer diagnosis

23 March 2021 - Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is ...

Read more →

FDA authorises first machine learning-based screening device to identify certain biomarkers that may indicate COVID-19 infection

19 March 2021 - Device may be used to identify biomarkers indicative of SARS-CoV-2 infection among certain asymptomatic individuals following a ...

Read more →

FDA releases artificial intelligence/machine learning action plan

12 January 2021 - Today, the U.S. FDA released the agency’s first artificial intelligence/machine learning-based software as a Medical Device Action ...

Read more →

Deep dive into big pharma AI productivity: one study shaking the pharmaceutical industry

15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from ...

Read more →

Randomised clinical trials of artificial intelligence

17 February 2020 - As patient data are increasingly captured digitally, the opportunities to deploy artificial intelligence, especially machine learning, ...

Read more →

Challenges to the reproducibility of machine learning models in health care

6 January 2020 - Reproducibility has been an important and intensely debated topic in science and medicine for the past few ...

Read more →

Lifecycle regulation of artificial intelligence and machine learning–based software devices in medicine

22 November 2019 - Artificial intelligence and machine learning (AI/ML) based technologies aim to improve patient care by uncovering new ...

Read more →

The FDA needs to set standards for using artificial intelligence in drug development

7 November 2019 - Artificial intelligence has become a crucial part of our technological infrastructure and the brain underlying many ...

Read more →

Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence

1 October 2019 - Multi-year alliance underpins the Novartis commitment to leverage data & artificial intelligence to transform how medicines are ...

Read more →